Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle

Archives of Surgery

Volumn 146, Issue 5, 2011, Pages 556-564

  Burgess, Thomas A ^a   Robich, Michael P ^a,b,c   Chu, Louis M ^b   Bianchi, Cesario ^a   Sellke, Frank W ^a,b,c  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; RESVERATROL; RETINOL BINDING PROTEIN 4; THREONINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE CONTROL STUDY; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; EUTHANASIA; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; IMMUNOBLOTTING; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; LIVER; LIVER FUNCTION TEST; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SWINE; WEIGHT CONTROL;

ANIMALS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIETARY CARBOHYDRATES; ENERGY INTAKE; ENERGY METABOLISM; INSULIN; INSULIN RESISTANCE; LIVER; LIVER FUNCTION TESTS; METABOLIC SYNDROME X; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION; STILBENES; SWINE; SWINE, MINIATURE; TREATMENT OUTCOME;

EID: 79956021270     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.100     Document Type: Article

References (34)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303(3):235-241.
2. Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197-1209. (Pubitemid 41393598)
3. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-1250. (Pubitemid 39202340)
4. Turcotte LP, Fisher JS. Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise. Phys Ther. 2008;88(11):1279-1296.
5. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119(5) (suppl 1):S10-S16.
6. Lovejoy JC. The influence of dietary fat on insulin resistance. Curr Diab Rep. 2002;2(5):435-440.
7. Schattenberg JM, Schuchmann M. Diabetes and apoptosis: liver. Apoptosis. 2009;14(12):1459-1471.
8. Harris EH. Elevated liver function tests in type 2 diabetes. Clin Diabetes. 2005;23(3):115-119. doi:10.2337/diaclin.23.3.115. (Pubitemid 41126805)
9. Sigal RJ, Kenny GP, Boulé NG, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147(6):357-369. (Pubitemid 351664536)
10. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625-633. (Pubitemid 46780646)
11. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323. (Pubitemid 351159368)
12. Breen DM, Sanli T, Giacca A, Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun. 2008;374(1):117-122.
13. Roccaro AM, Leleu X, Sacco A, et al. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia. Clin Cancer Res. 2008;14(6):1849-1858. (Pubitemid 351469472)
14. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127(6):1109-1122. (Pubitemid 44894520)
15. González-Rodríguez A, Mas Gutierrez JA, Sanz-González S, Ros M, Burks DJ, Valverde AM. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes. 2010;59(3):588-599.
16. Chaudhary N, Pfluger PT. Metabolic benefits from Sirt1 and Sirt1 activators. Curr Opin Clin Nutr Metab Care. 2009;12(4):431-437.
17. Institute of Laboratory Animal Resources; Commission on Life Sciences; National Research Council. Guide for the Care and Use of Laboratory Animals . Washington, DC: National Academy Press; 1996. Publication 5377-3.
18. Mattson MP. Perspective: does brown fat protect against diseases of aging? Ageing Res Rev. 2010;9(1):69-76.
19. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337-342. (Pubitemid 44764104)
20. Muoio DM, Newgard CB. Metabolism: A is for adipokine. Nature. 2005;436(7049):337-338. (Pubitemid 41059036)
21. Graham TE, Yang Q, Blüher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552-2563. (Pubitemid 43882351)
22. Higashida K, Higuchi M, Terada S. Dissociation between PGC-1alpha and GLUT-4 expression in skeletal muscle of rats fed a high-fat diet. J Nutr Sci Vitaminol (Tokyo). 2009;55(6):486-491.
23. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Biochem J. 1991;278(pt 3):609-619.
24. Ueda S, Kitazawa S, Ishida K, et al. Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma. FASEB J. 2010;24(7):2254-2261.
25. Cheng ZJ, Singh RD, Wang TK, et al. Stimulation of GLUT4 (glucose transporter isoform 4) storage vesicle formation by sphingolipid depletion. Biochem J. 2010;427(1):143-150.
26. Shepherd PR, Kahn BB. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999;341(4):248-257. (Pubitemid 29334524)
27. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002;53:409-435. (Pubitemid 34177889)
28. Cheatham WW. Peroxisome proliferator-activated receptor translational research and clinical experience. Am J Clin Nutr. 2010;91(1):262S-266S.
29. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37(5):1202-1219. (Pubitemid 36538699)
30. Roghani M, Baluchnejadmojarad T. Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats. Phytother Res. 2010;24(suppl 2):S148-S154.
31. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307(5712):1098- 1101. (Pubitemid 40262113)
32. Dong X, Park S, Lin X, Copps K, Yi X, White MF. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest. 2006;116(1):101-114. (Pubitemid 43121795)
33. Lipina C, Huang X, Finlay D, McManus EJ, Alessi DR, Sutherland C. Analysis of hepatic gene transcription in mice expressing insulin-insensitive GSK3. Biochem J. 2005;392(pt 3):633-639. (Pubitemid 43024281)
34. Gurusamy N, Lekli I, Mukherjee S, et al. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res. 2010;86(1):103-112.